"You decide and we provide."
Cart 0

BRIEF-European commission approves Bristol-Myers Squibb’s opdivo (nivolumab)




reutersCOMPANYNEWS companyNews

* European Commission approves Bristol-Myers Squibb’s opdivo (nivolumab) for previously treated locally advanced unresectable or metastatic urothelial carcinoma in adults after failure of prior platinum-containing therapy




Older Post Newer Post


Leave a comment

Please note, comments must be approved before they are published